Effect of ethanol on myocardial infarct size in a canine model of coronary artery occlusion-reperfusion.
This study was conducted to determine if elevated blood alcohol prior to acute coronary artery occlusion affects myocardial infarct size in an in vivo canine model. Seven pentobarbital anesthetized open-chest dogs received 10 min iv infusion of ethanol (0.08 g/kg/min). Ten min after ethanol, the left anterior descending coronary artery (LAD) was occluded distal to its first major branch for 60 min. The LAD was then reperfused for 5 h. Following electrically induced ventricular fibrillation, the area at risk of infarction was delineated with dye. The area of infarction was identified by staining with triphenyl tetrazolium chloride. Eleven untreated control experiments were also conducted. Mean blood ethanol concentration was 155+/-26 mg/dl just prior to LAD occlusion and 47+/-3 mg/dl after 4 h reperfusion. Ethanol infusion had no effect on systemic hemodynamic variables during ischemia. In ethanol treated animals, the area at risk was 19.7+/-3.0% of the left ventricle, and the infarct size was 20.9 +/-4.8% of the area at risk. In control experiments, the area at risk was 23.0+/-4.1% of the left ventricle (p > 0.05), and the infarct size was 21.6+/-3.8% of the area at risk (p > 0.05). Collateral blood flow to ischemic region did not differ between the two groups, and the relationships between infarct size and collateral flow were similar for control and untreated hearts. Acute ethanol exposure prior to coronary artery occlusion and subsequent reperfusion does not affect myocardial infarct size in the heart of the anesthetized dog.
Itoya
M
M
Department of Integrative Physiology, University of North Texas Health Science Center at Fort Worth, 76107-2699, USA.
Morrison
J D
JD
Downey
H F
HF
D000818:Animals; D003097:Collateral Circulation / Q000187:drug effects; D004396:Coloring Agents; D003331:Coronary Vessels; D004195:Disease Models, Animal; D004285:Dogs; D000431:Ethanol / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology* / Q000473:pathology* / Q000517:prevention & control; D015428:Myocardial Reperfusion Injury / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D013778:Tetrazolium Salts
D004396:Coloring Agents; D013778:Tetrazolium Salts; D000431:Ethanol; C009591:triphenyltetrazolium